UNSPSC 51101921: Chlorproguanil

This classification denotes an antiprotozoal agent with the molecular formula C11H15Cl2N5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8O3249M729, chemically known as 1-(3,4-dichlorophenyl)-5-isopropylbiguanide but generally known as chlorproguanil, which bears US NIH Compound Identifier 9571037. European Medicines Agency schedules Chlorproguanil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06207MIG.

UNSPSC 51101921 Chlorproguanil, a Commodity code, shows minimal recent state and local procurement activity aligned with its nominal scope. The two most recent opportunities tagged to this code involve pharmaceutical products — Doxycycline Hyclate, Ciprofloxacin Hydrochloride, and Naloxone — none of which are chlorproguanil, an antimalarial compound. State and local procurement offices appear to be using this code as a catch-all classification for pharmaceutical warehouse and emergency-response medical supply contracts rather than for chlorproguanil specifically. The actual buying under the code spans warehouse distribution of antibiotics and opioid-reversal agents through piggyback consortia and direct municipal procurement.

The issuing bodies include state health departments and county government purchasing offices. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 (closed award, not an open solicitation); Seminole County, Florida released an IFB in June 2026 for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries. Recent activity is concentrated in Florida and Illinois. The mismatch between the code's chemical name and the actual pharmaceutical products being procured suggests either cataloging error at the issuing-agency level or systemic misclassification of pharmaceutical supply contracts under this Commodity code. Firms pursuing this code should verify with individual procurement offices whether they intend to source chlorproguanil or are instead seeking pharmaceutical distributors for broad emergency-response and infectious-disease medications.